Ask.com
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Vamil Divan
Recent news which mentions Vamil Divan
Pfizer Analysts See 'Surprisingly Strong' Vaccine Updates In Q2, Question Biopharma's Blockbuster Potential
July 29, 2020
Tickers
MYL
PFE
UBS
Tags
Geoff Meacham
Top Stories
Benzinga
From
Benzinga
Credit Suisse Stays Sidelined On Teva: 'Our Growth Expectations Are Below That Of The Company'
February 14, 2019
Tickers
TEVA
Tags
Credit Suisse
Market News
Price Target
From
Benzinga
Credit Suisse Lifts Teva Price Target, Says Execution Is Key For Migraine Drug
September 17, 2018
Tickers
AMGN
LLY
NVS
TEVA
Tags
Vamil Divan
AMGN
Analyst Ratings
From
Benzinga
Sympathy Move: Portola Upgraded After Competitor Reports Sour Data
August 27, 2018
Tickers
BAYRY
JNJ
PTLA
Tags
Biotech
PTLA
General
From
Benzinga
Credit Suisse Downgrades AbbVie On Humira Competitive Concerns
May 30, 2018
Tickers
ABBV
Tags
Credit Suisse
Market News
Price Target
From
Benzinga
Portola Pharma Rips 20% Higher After FDA Approves Andexxa Antidote
May 04, 2018
Tickers
BAYRY
BMY
NEWS
PFE
Tags
BMY
News
FDA
From
Benzinga
Teva's 'Achievable' 2018 Outlook, Restructuring Plan Trigger Credit Suisse Upgrade
February 12, 2018
Tickers
TEVA
Tags
Pharmaceutical
Kare Schultz
israel
From
Benzinga
Eli Lilly's Challenges Leaves Credit Suisse With A 'Sour Taste'
January 22, 2018
Tickers
LLY
Tags
Downgrades
Top Stories
Diabetes
From
Benzinga
Credit Suisse Upgrades Teva After Job Cuts Announced
December 15, 2017
Tickers
TEVA
Tags
Vamil Divan
Analyst Color
Analyst Ratings
From
Benzinga
Could The Street Be Underappreciating The Ironwood Pharma Pipeline?
November 27, 2017
Tickers
IRWD
Tags
Credit Suisse
IRWD
Initiation
From
Benzinga
7 Catalysts For Eli Lilly Over The Next Year
October 10, 2017
Tickers
LLY
NEWS
Tags
Downgrades
News
Vamil Divan
From
Benzinga
Playing The US Pharma Space: Buy Portola, Hold Corvus, Sell Teva
August 24, 2017
Tickers
AGN
AIMT
ALDR
ALKS
Tags
Price Target
Credit Suisse
BevyxXa
From
Benzinga
Market Reaction To Bristol-Myers' Mixed Clinical Results: 'A Little Excessive'
August 16, 2017
Tickers
AZN
BMY
MRK
NEWS
Tags
FDA
sutent
News
From
Benzinga
Teva's Quarter: Earnings Miss, Guidance Cut, Dividend Devastated
August 03, 2017
Tickers
TEVA
Tags
Reiteration
Benzinga
Analyst Color
From
Benzinga
Johnson & Johnson Shares Strong Since Actelion Acquisition, But Potential For Upside Remains
July 20, 2017
Tickers
JNJ
Tags
M&A
Actelion
Trading Ideas
From
Benzinga
Analyst Prescribes Neutral Rating For Pfizer Shares
July 20, 2017
Tickers
NEWS
PFE
Tags
lyrica
Barclays
Viagra
From
Benzinga
Analyst Wonders If AstraZeneca's CEO Would Be A Fit At Teva
July 13, 2017
Tickers
AZN
NEWS
TEVA
Tags
Exclusives
Vamil Divan
Analyst Color
From
Benzinga
The Street May Be Underappreciating Alder Biopharma's Phase 3 Data
June 28, 2017
Tickers
ALDR
NEWS
Tags
Charles Duncan
ALDR
Downgrades
From
Benzinga
A Surprisingly Clean, Straightforward Approval Gives Portola Pharma Shares A Shot Of Upside
June 26, 2017
Tickers
BMY
MRK
NEWS
PFE
Tags
General
Movers
PTLA
From
Benzinga
Barictinib FDA Delay Only A 'Short-Term Setback' For Eli Lilly, Says Credit Suisse
January 17, 2017
Tickers
INCY
LLY
NEWS
Tags
FDA
News
Credit Suisse
From
Benzinga
Portola Announces FDA Drug Application Acceptance, Sets Up For A Pivotal Year Ahead
December 27, 2016
Tickers
NEWS
PTLA
Tags
Movers
PTLA
Biotech
From
Benzinga
Teva Pharmaceuticals Hit With A Slew Of Downgrades Following Guidance Revision
November 16, 2016
Tickers
NEWS
TEVA
Tags
teva
TEVA
David Steinberg
From
Benzinga
Teva Pharmaceuticals Could Be Poised For A Turnaround
October 31, 2016
Tickers
NEWS
TEVA
Tags
Earnings
Copaxone
TEVA
From
Benzinga
AbbVie's Humira Overhang Could Spell Trouble For Co.'s Future Upside
October 31, 2016
Tickers
ABBV
Tags
Credit Suisse
Price Target
Benzinga
From
Benzinga
Credit Suisse Changes Its View On Esperion Therapeutics, Raises Price Target
October 14, 2016
Tickers
ESPR
Tags
ESPR
Trading Ideas
Short Ideas
From
Benzinga
Credit Suisse Can Clearly See Why Johnson & Johnson Acquired Abbott's Optics Division
September 19, 2016
Tickers
JNJ
NEWS
Tags
News
JNJ
Abbott Medical Optics
From
Benzinga
Pfizer Has Emerged The Victor In The Buyout Battle For Medivation
August 22, 2016
Tickers
MDVN
PFE
Tags
Long Ideas
Trading Ideas
Analyst Ratings
From
Benzinga
CheckMate Miss Is A Game Changer; Credit Suisse Downgrades Bristol, Upgrades Merck
August 08, 2016
Tickers
BMY
MRK
Tags
BMY
Long Ideas
Downgrades
From
Benzinga
Allergan's Pipeline Is 'Underappreciated'
July 25, 2016
Tickers
AGN
TEVA
Tags
Trading Ideas
TEVA
Long Ideas
From
Benzinga
Esperion Therapeutics Downgraded On Regulatory Concerns By Credit Suisse
June 29, 2016
Tickers
ESPR
Tags
Analyst Color
Analyst Ratings
Vamil Divan
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.